常规体外受精流程中累积使用的耗材可能显示毒性
该观察性研究于2021年3月至2022年10月采用人类精子活力试验(HSMA)评估体外受精(IVF)耗材的累积毒性,先单独测试36种耗材(53批次),再测试48种组合;单独测试中4种(8%)有毒性,组合中17/48(35%)显示毒性,且毒性风险随耗材数量增加而升高(Cochran-Mantel-Haenszel统计量,P=0.013)。
要点
- 单独测试36种耗材中4种(8%)显示毒性,已从IVF常规流程中排除。
- 48种组合中17种(35%)在三次测试中两次或三次精子活力指数低于0.85。
- 毒性风险随组合中耗材数量增加而升高(Cochran-Mantel-Haenszel统计量,P=0.013)。
核心结论
- 当耗材累积使用时可能检测到毒性,而同一耗材单独使用和测试时未检测到毒性。
- 毒性并非来自单一耗材,因为组合中仅纳入单独预验证为无毒的耗材,毒性具有累积来源。
研究设计与样本
- 观察性研究,于2021年3月至2022年10月开展,采用人类精子活力试验(HSMA)方法。
- 研究14类常规IVF流程耗材,包括精子和卵母细胞采集、操作、培养和储存装置。
- 使用经患者同意、按世界卫生组织2010标准评估参数正常的剩余精液进行HSMA。
- 先单独测试每种耗材,再分析三种、四种和五种耗材的组合,HSMA重复三次以确保可重复性。
主要发现
- 36种耗材参考品在53批次中单独测试,49种(92%)符合要求,4种(8%)显示毒性:1批次1 ml注射器、2批次精液杯、1批次25 cm2培养瓶。
- 共评估48种耗材组合,涉及先前单独测试的32种参考品的41批次。
- 48种组合中17种(35%)显示毒性,精子活力指数低于0.85见于三次测试中的两次(n=8)或全部三次(n=9)。
- 17种中有3/17(18%)为三种耗材组合、5/16(31%)为四种耗材组合、9/15(60%)为五种耗材组合不符合要求。
- 累积毒性风险随组合中耗材数量增加而升高(Cochran-Mantel-Haenszel统计量,P=0.013)。
关键数值与推荐
- 毒性阈值定义为精子活力指数(SMI)低于0.85,且在三次测试中至少两次出现。
- 单独测试中4种(8%)耗材显示毒性,已从IVF常规流程中排除。
- 组合测试中17/48(35%)显示毒性,三种、四种、五种耗材组合的不符合率分别为3/17(18%)、5/16(31%)、9/15(60%)。
临床怎么用
- 作者认为,本研究强调在将耗材引入临床实践前进行毒性测试的重要性。
- 作者建议耗材应单独测试以检测即时毒性,也应进行组合测试。
- 作者主张合理化每次IVF流程中使用的耗材数量,并重新评估玻璃耗材的使用。
局限性
- 高比例的不符合组合可直接归因于测试中采用的极端严格提取条件,可能偏离常规临床使用条件。
- HSMA采用的方法(如毒性提取持续时间、精子浓度和培养基蛋白补充)可能影响测试的敏感性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is there a cumulative toxicity of disposables used in IVF procedures? SUMMARY ANSWER: A toxicity may be detected when consumables are used cumulatively, while no toxicity is detected when the same consumables are used and tested individually. WHAT IS KNOWN ALREADY: Many components of items used in IVF laboratories may impair human embryonic development. Consequently, it is necessary to screen all reagents and materials which could be in contact with gametes and embryos. Toxicity tests, such as the mouse embryo assay and the human sperm motility assay (HSMA), are used by manufacturers as quality control tools to demonstrate the safety of their products. This evaluation is currently individually performed for each single consumable. However, during an IVF cycle, several devices are used sequentially, potentially creating a cumulative exposure to chemical contaminants, which could not be detected for individually tested consumables. STUDY DESIGN, SIZE, DURATION: The objective of this observational study conducted from March 2021 to October 2022 was to evaluate with the HSMA methodology if there was a cumulative toxicity when several disposables are sequentially used. Fourteen categories of consumables currently used in routine IVF procedures were studied, which included devices used for sperm and oocyte collection (cups, condoms, and oocyte aspiration needles), manipulation (flasks, tubes, tips, pipettes, embryo transfer catheters, syringes, and gloves), culture (dishes), and storage (straws). PARTICIPANTS/MATERIALS, SETTING, METHODS: After obtaining patient consent, the surplus semen assessed as having normal parameters according to the World Health Organization 2010 criteria were used to perform the HSMAs. First, each consumable was tested individually. Then, associations of three, four, and five consumables, previously validated as non-toxic when tested individually, were analyzed. HSMAs were conducted three times to ensure reproducibility, with a defined toxicity threshold of a sperm motility index (SMI) below 0.85 in at least two of three tests. MAIN RESULTS AND THE ROLE OF CHANCE: Thirty-six references of disposables were first individually tested across 53 lots. Forty-nine (92%) demonstrated compliance. However, four (8%) devices revealed toxicity: one lot of 1 ml syringes, two lots of sperm cups, and one lot of 25 cm2 flasks. These four references were excluded from the IVF routine procedures. A total of 48 combinations of consumables were assessed, involving 41 lots from 32 references that were previously individually tested. Among the evaluated combinations, 17 out of 48 (35%) associations exhibited toxicity with a SMI below 0.85 for two of the three tests (n = 8) or all the three tests (n = 9). Notably, three out of 17 (18%) of the three-consumable associations, five out of 16 (31%) of the four-consumable associations, and nine out of 15 (60%) of the five-consumable associations were found not compliant. The toxicity did not originate from a single consumable, because only consumables that were individually pre-validated as non-toxic were included in the combinations, but the toxicity had a cumulative origin. The risk of cumulative toxicity increased with the number of consumables included in the association (Cochran-Mantel-Haenszel statistic, P = 0.013). LIMITATIONS, REASONS FOR CAUTION: The high proportion of non-compliant combinations of disposables can be attributed directly to the extreme rigorous extraction conditions employed during the tests, which could deviate from the conditions encountered in routine clinical use. Also, the methodology employed in the HSMAs (e.g. toxicity extraction duration, sperm concentrations, and protein supplementation of the medium) can influence the sensitivity of the tests. WIDER IMPLICATIONS OF THE FINDINGS: This study highlights the significance of performing toxicity testing on devices before introducing them into clinical practice. Disposables should be tested individually to detect immediate toxicities and also in combination. Our results advocate rationalizing the number of consumables used in each IVF procedure and re-evaluating the use of glass consumables. STUDY FUNDING/COMPETING INTEREST(S): This study received fundings from GCS Ramsay Santé pour l'Enseignement et la Recherche (Paris, France) and the Centre de Biologie Médicale BIOGROUP (Le Chesnay-Rocquencourt, France). The authors declare that they have no conflict of interest that could be perceived as prejudicing the impartiality of the reported research. TRIAL REGISTRATION NUMBER: N/A.
引用
- Delaroche L, Besnard L, Ouary V, et al. Disposables used cumulatively in routine IVF procedures could display toxicity. Hum Reprod. 2024. PMID: 38438162. doi:10.1093/humrep/deae028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。